60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) — Cash Flow-to-Debt Ratio
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a Cash Flow-to-Debt Ratio of -0.85x as of December 2025, meaning its operating cash flow of $-1.69 Million could theoretically repay -1% of its total liabilities ($1.99 Million) in one year. Check how high is 60 Degrees Pharmaceuticals, Inc. Common 's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
60 Degrees Pharmaceuticals, Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for 60 Degrees Pharmaceuticals, Inc. Common Stock across 6 annual periods. Also explore 60 Degrees Pharmaceuticals, Inc. Common total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for 60 Degrees Pharmaceuticals, Inc. Common Stock (2020–2025)
Year-by-year debt coverage analysis for 60 Degrees Pharmaceuticals, Inc. Common Stock. For market capitalisation and broader financial context, see market cap of 60 Degrees Pharmaceuticals, Inc. Common .
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.45x | $-6.85 Million | $1.99 Million | ▼ -10.1% |
| 2024 | -3.13x | $-5.65 Million | $1.80 Million | ▼ -105.7% |
| 2023 | -1.52x | $-4.54 Million | $2.99 Million | ▼ -3733.6% |
| 2022 | -0.04x | $-1.01 Million | $25.45 Million | ▼ -19.5% |
| 2021 | -0.03x | $-649.11K | $19.55 Million | ▼ -310.4% |
| 2020 | -0.01x | $-167.30K | $20.68 Million | — |